CD2ML
Board
2 directors, since incorporationManager (not named in the articles)
appointed by deed of 11-10-2018
term without a fixed end
listed in the 2025 annual accounts, filed on 30-07-2026
Manager (not named in the articles)
appointed by deed of 11-10-2018
listed in the 2025 annual accounts, filed on 30-07-2026
Mandates through the years
2 names, the dashed line is todayManager (not named in the articles)
Manager (not named in the articles)
Board
Mandates as a list
-
- Manager (not named in the articles), appointed by deed of 11-10-2018, still in office
-
- Manager (not named in the articles), appointed by deed of 11-10-2018, still in office
Control
Founders
,
This company
CD2ML
Equity €20,637
Profit €76,464 in 2025
Capital
- Contribution
- €18,600
- Shares
- 100
- Contribution per share
- €186
- Equity per share
- €206 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 25-02-2021 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Rémunération des administrateurs, fixe ou proportionnelle”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Monday of May at 18:00
Founders
At incorporation
deed of 11-10-2018 ↗
- founder
- founder
Capital transactions
Capital over time
- 25-02-2021 Converted to unavailable equity
- 11-10-2018 Incorporation · €18,600 · 100 shares